OTC · Biotechnology

Bonus Biogroup Ltd. (BBIXF) Stock

$0.10 +0.00% OTC: BBIXF Healthcare

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients.

Valuation

MetricValue
Price$0.10
Market Cap$110.95M
P/E Ratio-25.29
P/B Ratio-53.20
P/S Ratio0.00
EPS (TTM)$-0.04
52-Week High$0.15
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE667.39%
ROA-158.60%
ROCE-2300.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-1.57
Current Ratio0.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-65.0M$-37.0M$-30.0M$-28.0M$-23.0M
Net Profit$-90.0M$-39.0M$-29.0M$-28.0M$-24.0M
EPS$-0.08$-0.03$-0.02$-0.02$-0.04
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$104.0M$75.0M$45.0M$23.0M$15.0M
Total Liabilities$20.0M$18.0M$16.0M$16.0M$21.0M
Cash$79.0M$54.0M$13.0M$7.0M$0
Borrowings$12.0M$12.0M$11.0M$10.0M$9.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-40.0M$-29.0M$-26.0M$-21.0M$-15.0M
Investing Cash Flow$-12.0M$-13.0M$-15.0M$12.0M$0
Financing Cash Flow$4.0M$-1.0M$-1.0M$-1.0M$-1.0M
Net Cash Flow$63.0M$-26.0M$-41.0M$-6.0M$-6.0M
Free Cash Flow$-46.0M$-35.0M$-27.0M$-22.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.18
EV / EBITDA-13.95
FCF Yield-4.96%
Quick Ratio0.13
Interest Coverage-58.37
Return 1Y137.50%
Return 3Y375.00%
Return 5Y—

Ownership

Insiders Held45.05%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLCSCell Source, Inc. $0.80 -6.98% -8.00 $36.03M 0.00%
CLIFFCordlife Group Limited $0.09 -40.12% -3.10 $23.09M 0.00%
CLYYFCelyad Oncology S.A. $0.20 +0.00% 14.03 $8.95M 0.00%
ELVAFEvoNext Holdings S.A. $2.15 +0.00% -23.56 $15.50M 0.00%
FNCHFinch Therapeutics Group, Inc. $9.60 -3.71% -1.11 $15.42M 0.00%

About Bonus Biogroup Ltd.

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is headquartered in Haifa, Israel.

Bonus Biogroup Ltd. is headquartered in IL.

Bonus Biogroup Ltd. (BBIXF) stock trades at $0.10 with a market capitalization of $110.95M. The stock is valued at a price-to-earnings (P/E) ratio of -25.29, price-to-book of -53.20, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.15, and currently trades 33.3% below its 52-week high.

On profitability, Bonus Biogroup Ltd. generates a return on equity (ROE) of 667.39% — well above the market average, a sign of a high-quality business, return on capital employed of -2300.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: bonus-bio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides